Canopy, based in Smiths Falls, Ont., produces and sells medical cannabis and cannabinoid-based consumer products in Canada ...

Canopy Growth reported improved financial results for Q2, with higher revenue and improved net loss. Find out why CGC stock ...

Canopy Growth (CGC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Canopy Growth (TSX:WEED)(NASDAQ:CGC) stock climbed 10% on Monday and 18% since bottoming out last week. But is the volatile stock now a buy? Canopy Growth stock announced last week that its Tweed ...

September saw an intensification of pressure on the economy and markets. Interest rate hikes continued – foretelling economic woes and company troubles. In turn, this has exasperated investors’ ...

Shares of Canopy Growth Corp. WEED-T dropped by 40 per cent Friday after the company announced it was issuing new shares to reduce its debt load, just one day before a key debt maturity. Canopy said ...

Canopy Growth’s (TSX:WEED)(NYSE:CGC) stock price fell 5% on Thursday after the leading cannabis firm announced its acquisition of a competitor at a 66% premium to Wednesday’s closing prices. The ...

Recall Canopy Growth stock also plunged more than 35% last week when the company unveiled the structure of the then-pending 1-for-10 "share consolidation," otherwise known as a reverse-stock split.

Canopy Growth’s latest results showcased stronger execution and renewed momentum across key markets. Is CGC stock finally ...

Ottawa-area marijuana producer Canopy Growth Corp. (TSX:CGC) is offering to buy Mettrum Health Corp. (TSXV:MT) in a friendly all-stock deal valued at $430 million. Mettrum shareholders will be ...

Canopy Growth (CGC) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.